Kylin Therapeutics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

Kylin Therapeutics General Information

Description

Operator of a biotechnology company. The company employs a RNA nanoparticle technology platform called pRNA to utilize the potential of RNA interference (RNAi) for treatment of cancer and cancer related diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3000 Kent Avenue
  • West Lafayette, IN 47906
  • United States
+1 (765)
Primary Industry
Biotechnology
Acquirer
Guangzhou Biomotor and RNA Nanotech Development Company
Corporate Office
  • 3000 Kent Avenue
  • West Lafayette, IN 47906
  • United States
+1 (765)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kylin Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kylin Therapeutics‘s full profile, request access.

Request a free trial

Kylin Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kylin Therapeutics‘s full profile, request access.

Request a free trial

Kylin Therapeutics FAQs

  • When was Kylin Therapeutics founded?

    Kylin Therapeutics was founded in 2006.

  • Where is Kylin Therapeutics headquartered?

    Kylin Therapeutics is headquartered in West Lafayette, IN.

  • What industry is Kylin Therapeutics in?

    Kylin Therapeutics’s primary industry is Biotechnology.

  • Is Kylin Therapeutics a private or public company?

    Kylin Therapeutics is a Private company.

  • What is Kylin Therapeutics’s current revenue?

    The current revenue for Kylin Therapeutics is .

  • How much funding has Kylin Therapeutics raised over time?

    Kylin Therapeutics has raised $3.84M.

  • Who are Kylin Therapeutics’s investors?

    Elevate Ventures, Golden Pine Ventures, In-Vivo Ventures, and Purdue University Endowment have invested in Kylin Therapeutics.

  • When was Kylin Therapeutics acquired?

    Kylin Therapeutics was acquired on 01-Aug-2012.

  • Who acquired Kylin Therapeutics?

    Kylin Therapeutics was acquired by Guangzhou Biomotor and RNA Nanotech Development Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »